首页|期刊导航|眼科新进展|YAP1通过结合TEAD2调控靶基因BIRC5参与人晶状体上皮细胞上皮-间质转化

YAP1通过结合TEAD2调控靶基因BIRC5参与人晶状体上皮细胞上皮-间质转化OA

中文摘要英文摘要

目的 探讨Yes相关蛋白1(YAP1)通过结合转录增强结构域转录因子2(TEAD2)调控靶基因杆状病毒凋亡抑制蛋白5(BIRC5)参与人晶状体上皮细胞(LECs)上皮-间质转化(EMT)的过程.方法 将HLE-B3细胞分为Vector组、OE-YAP1 组以及OE-TEAD2 组,分别转染 pCDNA3.1-Vector、pCDNA3.1-YAP1和pCDNA3.1-TEAD2,倒置荧光显微镜下观察其转染成功情况.转染成功后将培养的HLE-B3细胞采用10 μg·L-1转化生长因子-β2的DEME继续培养24 h,分为Vector+T空载体组、OE-YAP1+T转染组、OE-TEAD2+T转染组和OE-YAP1+OE-TEAD2+T共转染组.实时荧光定量PCR与 Western blot检测各组细胞中YAP1、TEAD2、BIRC5以及E-钙黏蛋白(E-cadherin)、α-平滑肌肌动蛋白(α-SMA)、波形蛋白(Vimentin)的mRNA与蛋白相对表达量.分别构建含结合位点的野生型载体pGL3-basic-BIRC5-WT与含有突变位点的突变型载体pGL3-basic-BIRC5-MUT,均转染pCDNA3.1-TEAD2或pCDNA3.1-Vector至HLE-B3细胞中,利用双荧光素酶报告基因实验验证TEAD2与BIRC5的相互作用关系.结果 Vector组、OE-YAP1组以及OE-TEAD2组细胞中过表达质粒YAP1、过表达质粒TEAD2及空载体均能高度表达,可用于后续实验.OE-YAP1+OE-TEAD2+T共转染组细胞中YAP1、TEAD2、BIRC5蛋白及mRNA相对表达量均高于Vector+T空载体组与OE-YAP1+T转染组,差异均有统计学意义(均为P<0.05).与Vector+T空载体组及OE-YAP1+T转染组细胞相比,OE-YAP1+OE-TEAD2+T共转染组细胞中E-cadherin蛋白及mRNA相对表达量均较低,α-SMA、Vimentin蛋白及mRNA相对表达量均较高,差异均有统计学意义(均为P<0.05).双荧光素酶报告基因实验结果证实,TEAD2对于BIRC5转录具有激活因子功能.结论 YAP1可通过结合TEAD2调控靶基因BIRC5参与LECs的EMT,为防治后发性白内障提供新的思路.

Objective To explore the involvement of Yes-associated protein 1(YAP1)in the epithelial-mesenchymal transition(EMT)of human lens epithelial cells(LECs)by binding to transcriptional enhancer domain transcription factor 2(TEAD2)to regulate the target gene baculovirus inhibitor of apoptosis protein 5(BIRC5).Methods HLE-B3 cells were divided into the Vector group,OE-YAP1 group,and OE-TEAD2 group,and transfected with pCDNA3.1-Vector,pCDNA3.1-YAP1,and pCDNA3.1-TEAD2,respectively.The transfection was observed under an inverted fluorescence microscope.After successful transfection,the cultured HLE-B3 cells were further cultured for 24 hours using DEME with 10 μg·L-1 transfor-ming growth factor-β2 and divided into the Vector+T empty vector group,OE-YAP1+T transfection group,OE-TEAD2+T transfection group,and OE-YAP1+OE-TEAD2+T co-transfection group.Real-time fluorescence quantitative PCR and West-ern blot were used to detect the relative mRNA and protein expression levels of YAP1,TEAD2,BIRC5,E-cadherin,α-smooth muscle actin(α-SMA),and Vimentin in each group of cells.Wild-type vector pGL3-basic-BIRC5-WT containing binding sites and mutant vector pGL3-basic-BIRC5-MUT containing mutation sites were constructed and transfected with pCDNA3.1-TED2 or pCDNA3.1-Vector into HLE-B3 cells.The interaction between TEAD2 and BIRC5 was verified using the dual lucif-erase reporter gene assay.Results The overexpression plasmids YAP1 and TEAD2,as well as the empty vector,were highly expressed in cells in the Vector group,OE-YAP1 group,and OE-TEAD2 group,and can be used for subsequent experi-ments.The relative protein and mRNA expression levels of YAP1,TEAD2,and BIRC5 in the OE-YAP1+OE-TEAD2+T co-transfection group were higher than those in the Vector+T empty vector group and the OE-YAP1+T transfection group,and the differences were statistically significant(all P<0.05).Compared with the Vector+T empty vector group and the OE-YAP1+T transfection group,the OE-YAP1+OE-TEAD2+T co-transfection group had lower protein and mRNA expression levels of E-cadherin and higher protein and mRNA expression levels of α-SMA and Vimentin,with statistically significant differences(all P<0.05).The results of the dual luciferase reporter gene assay confirmed that TEAD2 could activate the transcription of BIRC5.Conclusion YAP1 can regulate the target gene BIRC5 to participate in the EMT of LECs by bind-ing to TEAD2,providing a new approach for the prevention and treatment of posterior capsular opacification.

黄建环;郑柳;蒋姣姣;苏星宇;杨彬彬;李金清;陆素青;丁芝祥

541000 广西壮族自治区桂林市,桂林医科大学第一附属医院541000 广西壮族自治区桂林市,桂林医科大学第一附属医院541000 广西壮族自治区桂林市,桂林医科大学第一附属医院541000 广西壮族自治区桂林市,桂林医科大学第一附属医院541000 广西壮族自治区桂林市,桂林医科大学第一附属医院541000 广西壮族自治区桂林市,桂林医科大学第一附属医院541000 广西壮族自治区桂林市,桂林医科大学第一附属医院541000 广西壮族自治区桂林市,桂林医科大学第一附属医院

医药卫生

人晶状体上皮细胞上皮-间质转分化转录增强结构域转录因子2杆状病毒凋亡抑制蛋白5Hippo/Yes相关蛋白信号通路

human lens epithelial cellsepithelial-mesenchymal transitiontranscriptional enhancer domain transcrip-tion factor 2baculovirus inhibitor of apoptosis protein 5Hippo/Yes-associated protein signaling pathway

《眼科新进展》 2026 (6)

437-442,6

国家自然科学基金项目(编号:8216040180)桂林市科学研究与技术开发计划项目[编号:市科(2024)17号(20230121-7)]

10.13389/j.cnki.rao.2026.0078

评论